Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-180.31	-73.90	-26.36
Graham Fair Price	-64.86	3.00	8.53
PEG	71489.17	-0.14	< 0.005
Price/Book	-25.20	1.44	1.93
Price/Cash Flow	-851.36	-38.09	-4.00
Prices/Earnings	-527.62	-12.18	-1.94
Price/Sales	16.51	6.70	5.75
Price/FCF	-851.36	-38.09	-4.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-56.23	0.07	0.16
Operating Margin	85.02	-0.13	-0.87
ROA	88.45	-0.01	-0.10
ROE	-0.25	-0.03	88.08
ROIC	-0.15	-0.02	85.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.62	99.82
Dividends QOQ	69.65	-0.99	-98.57
EBIT QOQ	-61.47	0.91	-98.53
EPS QOQ	-100.12	0.88	-99.12
FCF QOQ	-69.92	0.92	-98.68
Revenue QOQ	-0.11	-0.37	-237.08
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	43.74	65.17	49.00
Days Sales Outstanding (DSO)	803.24	1423.34	77.20
Inventory Turnover	2.06	1.38	-32.89
Debt/Capitalization	0.24	0.24	1.92
Quick Ratio	0.65	0.64	-1.47
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.61	3.67	1.80
Cash	0.59	0.37	-38.08
Capex	-0.84	-0.03	96.39
Free Cash Flow	-1.74	-0.14	92.00
Revenue	1.21	0.79	-34.64
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.76	0.75	-1.13
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.99	-10.15	-411.06
Naive Interpretation	Member

06 - Financial Health · Bad

Rating